Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments (2018 - 2024)

Palvella Therapeutics (PVLA) has reported Change in Acquisitions & Divestments for 6 consecutive years, with $9.0 million the latest figure, recorded in Q1 2024.

• In Q1 2024, Change in Acquisitions & Divestments fell 33.31% year-over-year to $9.0 million; the TTM figure through Sep 2024 stood at $20.0 million (down 34.01% YoY), while the FY2023 annual figure was $35.0 million, up 24.14% from the prior year.
• Change in Acquisitions & Divestments eased to $9.0 million in Q1 2024 per PVLA's latest filing, from $11.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $28.4 million in Q1 2020 and bottomed at $4.8 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $13.0 million across 4 years, with a median of $12.2 million in 2023.
• Annual changes were most pronounced in 2020 — Change in Acquisitions & Divestments jumped 898.35% — and 2023, when it plunged 70.02%.
• Palvella Therapeutics' Change in Acquisitions & Divestments stood at $15.8 million in 2020, then slumped by 60.0% to $6.3 million in 2022, then surged by 74.62% to $11.0 million in 2023, then dropped by 18.19% to $9.0 million in 2024.
• Business Quant data shows PVLA's Change in Acquisitions & Divestments at $9.0 million in Q1 2024, $11.0 million in Q4 2023, and $5.1 million in Q3 2023.